The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharmaceutical Plastics Market Research Report 2025
Synopsis
Global Biopharmaceutical Plastics market is projected to reach US$ 9965.6 million in 2029, increasing from US$ 4800 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceutical Plastics market research.
Key manufacturers engaged in the Biopharmaceutical Plastics industry include BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont, Tekni-Plex, Inc., Solvay S.A., Avantor, Inc. and Bormioli Pharma S.p.A., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global Biopharmaceutical Plastics production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of Biopharmaceutical Plastics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biopharmaceutical Plastics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biopharmaceutical Plastics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF SE
Spectrum Plastics Group
Celanese Corporation
LyondellBasell Industries Holdings B.V.
DuPont
Tekni-Plex, Inc.
Solvay S.A.
Avantor, Inc.
Bormioli Pharma S.p.A.
Saudi Basic Industries Corporation
Segment by Type
Polyvinyl Chloride
Polyethylene Terephthalate
Polypropylene
Others
Segment by Application
Protective Wear
Bioreactor Bags
Syringes
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Biopharmaceutical Plastics report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Global Biopharmaceutical Plastics market is projected to reach US$ 9965.6 million in 2029, increasing from US$ 4800 million in 2022, with the CAGR of 11.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceutical Plastics market research.
Key manufacturers engaged in the Biopharmaceutical Plastics industry include BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont, Tekni-Plex, Inc., Solvay S.A., Avantor, Inc. and Bormioli Pharma S.p.A., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global Biopharmaceutical Plastics production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of Biopharmaceutical Plastics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biopharmaceutical Plastics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biopharmaceutical Plastics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF SE
Spectrum Plastics Group
Celanese Corporation
LyondellBasell Industries Holdings B.V.
DuPont
Tekni-Plex, Inc.
Solvay S.A.
Avantor, Inc.
Bormioli Pharma S.p.A.
Saudi Basic Industries Corporation
Segment by Type
Polyvinyl Chloride
Polyethylene Terephthalate
Polypropylene
Others
Segment by Application
Protective Wear
Bioreactor Bags
Syringes
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Biopharmaceutical Plastics report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Biopharmaceutical Plastics Market Overview
1.1 Product Definition
1.2 Biopharmaceutical Plastics Segment by Type
1.2.1 Global Biopharmaceutical Plastics Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Polyvinyl Chloride
1.2.3 Polyethylene Terephthalate
1.2.4 Polypropylene
1.2.5 Others
1.3 Biopharmaceutical Plastics Segment by Application
1.3.1 Global Biopharmaceutical Plastics Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Protective Wear
1.3.3 Bioreactor Bags
1.3.4 Syringes
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Biopharmaceutical Plastics Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Biopharmaceutical Plastics Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Biopharmaceutical Plastics Production Estimates and Forecasts (2018-2029)
1.4.4 Global Biopharmaceutical Plastics Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Biopharmaceutical Plastics Production Market Share by Manufacturers (2018-2023)
2.2 Global Biopharmaceutical Plastics Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Biopharmaceutical Plastics, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Biopharmaceutical Plastics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Biopharmaceutical Plastics Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Biopharmaceutical Plastics, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Biopharmaceutical Plastics, Product Offered and Application
2.8 Global Key Manufacturers of Biopharmaceutical Plastics, Date of Enter into This Industry
2.9 Biopharmaceutical Plastics Market Competitive Situation and Trends
2.9.1 Biopharmaceutical Plastics Market Concentration Rate
2.9.2 Global 5 and 10 Largest Biopharmaceutical Plastics Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Biopharmaceutical Plastics Production by Region
3.1 Global Biopharmaceutical Plastics Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Biopharmaceutical Plastics Production Value by Region (2018-2029)
3.2.1 Global Biopharmaceutical Plastics Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Biopharmaceutical Plastics by Region (2024-2029)
3.3 Global Biopharmaceutical Plastics Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Biopharmaceutical Plastics Production by Region (2018-2029)
3.4.1 Global Biopharmaceutical Plastics Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Biopharmaceutical Plastics by Region (2024-2029)
3.5 Global Biopharmaceutical Plastics Market Price Analysis by Region (2018-2023)
3.6 Global Biopharmaceutical Plastics Production and Value, Year-over-Year Growth
3.6.1 North America Biopharmaceutical Plastics Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Biopharmaceutical Plastics Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Biopharmaceutical Plastics Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Biopharmaceutical Plastics Production Value Estimates and Forecasts (2018-2029)
4 Biopharmaceutical Plastics Consumption by Region
4.1 Global Biopharmaceutical Plastics Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Biopharmaceutical Plastics Consumption by Region (2018-2029)
4.2.1 Global Biopharmaceutical Plastics Consumption by Region (2018-2023)
4.2.2 Global Biopharmaceutical Plastics Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Biopharmaceutical Plastics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Biopharmaceutical Plastics Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Biopharmaceutical Plastics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Biopharmaceutical Plastics Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Biopharmaceutical Plastics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Biopharmaceutical Plastics Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Biopharmaceutical Plastics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Biopharmaceutical Plastics Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Biopharmaceutical Plastics Production by Type (2018-2029)
5.1.1 Global Biopharmaceutical Plastics Production by Type (2018-2023)
5.1.2 Global Biopharmaceutical Plastics Production by Type (2024-2029)
5.1.3 Global Biopharmaceutical Plastics Production Market Share by Type (2018-2029)
5.2 Global Biopharmaceutical Plastics Production Value by Type (2018-2029)
5.2.1 Global Biopharmaceutical Plastics Production Value by Type (2018-2023)
5.2.2 Global Biopharmaceutical Plastics Production Value by Type (2024-2029)
5.2.3 Global Biopharmaceutical Plastics Production Value Market Share by Type (2018-2029)
5.3 Global Biopharmaceutical Plastics Price by Type (2018-2029)
6 Segment by Application
6.1 Global Biopharmaceutical Plastics Production by Application (2018-2029)
6.1.1 Global Biopharmaceutical Plastics Production by Application (2018-2023)
6.1.2 Global Biopharmaceutical Plastics Production by Application (2024-2029)
6.1.3 Global Biopharmaceutical Plastics Production Market Share by Application (2018-2029)
6.2 Global Biopharmaceutical Plastics Production Value by Application (2018-2029)
6.2.1 Global Biopharmaceutical Plastics Production Value by Application (2018-2023)
6.2.2 Global Biopharmaceutical Plastics Production Value by Application (2024-2029)
6.2.3 Global Biopharmaceutical Plastics Production Value Market Share by Application (2018-2029)
6.3 Global Biopharmaceutical Plastics Price by Application (2018-2029)
7 Key Companies Profiled
7.1 BASF SE
7.1.1 BASF SE Biopharmaceutical Plastics Corporation Information
7.1.2 BASF SE Biopharmaceutical Plastics Product Portfolio
7.1.3 BASF SE Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.1.4 BASF SE Main Business and Markets Served
7.1.5 BASF SE Recent Developments/Updates
7.2 Spectrum Plastics Group
7.2.1 Spectrum Plastics Group Biopharmaceutical Plastics Corporation Information
7.2.2 Spectrum Plastics Group Biopharmaceutical Plastics Product Portfolio
7.2.3 Spectrum Plastics Group Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Spectrum Plastics Group Main Business and Markets Served
7.2.5 Spectrum Plastics Group Recent Developments/Updates
7.3 Celanese Corporation
7.3.1 Celanese Corporation Biopharmaceutical Plastics Corporation Information
7.3.2 Celanese Corporation Biopharmaceutical Plastics Product Portfolio
7.3.3 Celanese Corporation Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Celanese Corporation Main Business and Markets Served
7.3.5 Celanese Corporation Recent Developments/Updates
7.4 LyondellBasell Industries Holdings B.V.
7.4.1 LyondellBasell Industries Holdings B.V. Biopharmaceutical Plastics Corporation Information
7.4.2 LyondellBasell Industries Holdings B.V. Biopharmaceutical Plastics Product Portfolio
7.4.3 LyondellBasell Industries Holdings B.V. Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.4.4 LyondellBasell Industries Holdings B.V. Main Business and Markets Served
7.4.5 LyondellBasell Industries Holdings B.V. Recent Developments/Updates
7.5 DuPont
7.5.1 DuPont Biopharmaceutical Plastics Corporation Information
7.5.2 DuPont Biopharmaceutical Plastics Product Portfolio
7.5.3 DuPont Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.5.4 DuPont Main Business and Markets Served
7.5.5 DuPont Recent Developments/Updates
7.6 Tekni-Plex, Inc.
7.6.1 Tekni-Plex, Inc. Biopharmaceutical Plastics Corporation Information
7.6.2 Tekni-Plex, Inc. Biopharmaceutical Plastics Product Portfolio
7.6.3 Tekni-Plex, Inc. Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Tekni-Plex, Inc. Main Business and Markets Served
7.6.5 Tekni-Plex, Inc. Recent Developments/Updates
7.7 Solvay S.A.
7.7.1 Solvay S.A. Biopharmaceutical Plastics Corporation Information
7.7.2 Solvay S.A. Biopharmaceutical Plastics Product Portfolio
7.7.3 Solvay S.A. Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Solvay S.A. Main Business and Markets Served
7.7.5 Solvay S.A. Recent Developments/Updates
7.8 Avantor, Inc.
7.8.1 Avantor, Inc. Biopharmaceutical Plastics Corporation Information
7.8.2 Avantor, Inc. Biopharmaceutical Plastics Product Portfolio
7.8.3 Avantor, Inc. Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Avantor, Inc. Main Business and Markets Served
7.7.5 Avantor, Inc. Recent Developments/Updates
7.9 Bormioli Pharma S.p.A.
7.9.1 Bormioli Pharma S.p.A. Biopharmaceutical Plastics Corporation Information
7.9.2 Bormioli Pharma S.p.A. Biopharmaceutical Plastics Product Portfolio
7.9.3 Bormioli Pharma S.p.A. Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Bormioli Pharma S.p.A. Main Business and Markets Served
7.9.5 Bormioli Pharma S.p.A. Recent Developments/Updates
7.10 Saudi Basic Industries Corporation
7.10.1 Saudi Basic Industries Corporation Biopharmaceutical Plastics Corporation Information
7.10.2 Saudi Basic Industries Corporation Biopharmaceutical Plastics Product Portfolio
7.10.3 Saudi Basic Industries Corporation Biopharmaceutical Plastics Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Saudi Basic Industries Corporation Main Business and Markets Served
7.10.5 Saudi Basic Industries Corporation Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Biopharmaceutical Plastics Industry Chain Analysis
8.2 Biopharmaceutical Plastics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Biopharmaceutical Plastics Production Mode & Process
8.4 Biopharmaceutical Plastics Sales and Marketing
8.4.1 Biopharmaceutical Plastics Sales Channels
8.4.2 Biopharmaceutical Plastics Distributors
8.5 Biopharmaceutical Plastics Customers
9 Biopharmaceutical Plastics Market Dynamics
9.1 Biopharmaceutical Plastics Industry Trends
9.2 Biopharmaceutical Plastics Market Drivers
9.3 Biopharmaceutical Plastics Market Challenges
9.4 Biopharmaceutical Plastics Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
